Avigdor Nosrati
Resident · University of Southern California/Los Angeles General Medical Center
Credentials: · ·
History
- 2023–2024
Preliminary or Transitional Year
2019–2023
Research
Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa
JAMA Dermatology · 2024 · First of 12 authors · 25 citations
Adalimumab efficacy is inversely correlated with body mass index (BMI) in hidradenitis suppurativa
International Journal of Dermatology · 2023 · First of 10 authors · 15 citations
Patient satisfaction with hidradenitis suppurativa televisits correlates with less severe disease
Journal of the American Academy of Dermatology · 2022 · 3 citations
- SC
5 papers
4 papers · 3 as a resident
- KC
4 papers
4 papers · 4 as a resident
4 papers · 3 as a resident
2 papers · 2 as a resident
2 papers
- AC
1 paper
